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Background: Vitamin D status is hypothesised to play a role in gestational glucose control. No studies to date
have examined vitamin D in relation to changes in blood glucose in pregnancy. Thus, the aim was to examine if
vitamin D in early pregnancy and vitamin D trajectory associate with blood glucose trajectory over pregnancy in
a Swedish cohort. We also investigated the relation between maternal vitamin D status and excessive fetal
growth.
Methods: In 2013–2014, pregnant women were recruited to the GraviD cohort study when registering at the
antenatal clinics in south-west Sweden. In the present analysis, 1928 women were included. Women with
preexisting diabetes and multifetal pregnancy were excluded. Random blood glucose was assessed according to
routine practice, in first trimester (T1, gestational week 4–16), second trimester (T2, gestational week 17–27),
early (T3a, gestational week 28–35) and late third trimester (T3b, gestational week 36–41). In T1 and T3a,
serum 25-hydroxyvitamim D (25OHD) was analyzed by liquid chromatography tandem mass spectrometry.
Large for gestational age (LGA), as a proxy of excessive fetal growth, was defined as body weight at birth above 2
standard deviations of the gender specific population mean. Adjusted linear regression, linear mixed models
analysis and logistic regression analysis were used to study 25OHD in relation to T1 blood glucose, glucose
trajectory and LGA, respectively.
Results: Mean blood glucose increased during pregnancy (5.21 mmol/L in T1, 5.27 mmol/L in T2, 5.31 mmol/L
in T3a and 5.34 mmol/L in T3b; p = 0.003). In T1, 25OHD was negatively associated with blood glucose, i.e.
25OHD ≥ 30 nmol/L was associated with 0.25-0.35 mmol/L lower glucose. T1 25OHD was also negatively associated with blood glucose trajectory. Higher T3 25OHD was associated with higher odds of LGA (p = 0.032).
Conclusion: Avoiding maternal vitamin D deficiency in early pregnancy is associated with lower blood glucose in
early pregnancy and throughout pregnancy. Higher 25OHD in late pregnancy was associated with higher odds of
LGA at birth.

1. Introduction
Global estimates from 2013 indicate that 21.4 million live births
were affected by hyperglycaemia in pregnancy [1]. It is well-established that increased glycaemia creates an unfavourable environment
for embryonic and foeto-placental development [2]. For example, results from the large Hyperglycemia and Adverse Pregnancy Outcomes
(HAPO) study shows a continuous graded relationship between higher
maternal blood glucose concentration and increasing frequency of
serious neonatal and maternal complications, including increased risk
of large for gestational age (LGA) infants [3].

Recent literature identifies a possible role of vitamin D as a modulator of gestational glucose control and hyperglycaemia in pregnancy,
including gestational diabetes mellitus (GDM) [4,5]. Thus, the maternal
vitamin D status may be important for gestational glucose control and
of major clinical significance to maternal and neonatal health in pregnancy. Circulating concentrations of 25-hydroxyvitamin D (25OHD) in
serum or plasma is the most widely used biomarker of vitamin D status
[6]. Currently, there are no pregnancy-specific 25OHD thresholds to
constitute vitamin D adequacy. Thus, cut-offs for the adult population
are often adopted for pregnant women [7]. The Institute of Medicine
define vitamin D deficiency as 25OHD concentrations < 30 nmol/L for

Abbreviations: LGA, large for gestational age; HAPO, Hyperglycemia and Adverse Pregnancy Outcomes; 25OHD, 25-hydroxyvitamin D; GDM, gestational diabetes
mellitus; T1, trimester 1; T2, trimester 2; T3, trimester 3; BMI, body mass index
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both the general and pregnant population [8]; a cut-off also adopted by
Nordic nutrition recommendations [9]. In accordance with this cut-off,
the prevalence of vitamin D deficiency is about 10% amongst pregnant
women in Sweden in first trimester, with higher rates observed among
women of African and Asian descent [10].
Poor vitamin D status is theorised to exacerbate insulin resistance
and hyperglycaemia in the pregnant state via its involvement in pancreatic β-cell function [11], insulin sensitivity [12] and inflammation
[13]. In non-diabetic pregnant cohorts, vitamin D deficiency has been
inversely associated with altered glucose homeostasis including fasting
glucose levels, post-prandial glucose levels, β-cell function and insulin
resistance [14,15]. Individual observational studies and meta-analyses
support the linkage between maternal vitamin D deficiency and GDM
development [16–19]. These studies are however, cross-sectional in
nature and predominantly examine the influence of vitamin D in the
second trimester of pregnancy. Studies examining the effects of vitamin
D status in first trimester on subsequent glucose metabolism are limited
and the few studies available have produced disparate results [20–25].
Given the possible effects of vitamin D metabolism on glucose metabolism in pregnancy, it is likely that longitudinal changes in 25OHD
in pregnancy (vitamin D trajectory) also have an important effect on
glucose control throughout pregnancy (glucose trajectory). However, to
our knowledge, no studies to date have examined the relation between
vitamin D trajectory and blood glucose trajectory throughout pregnancy in either non-diabetic or diabetic cohorts.
Therefore, the objectives were to examine if maternal vitamin D in
early pregnancy and vitamin D trajectory associate with blood glucose
trajectory in pregnancy. We also investigated the relation between
maternal vitamin D status and odds of having a LGA infant.

2.3. Laboratory analysis
Blood glucose was measured in blood collected using a finger prick
test method, according to standard practice. The HemoCue® Beta-glucose analyzer is the most commonly used point-of-care glucose monitoring device in antenatal care settings in Sweden.
Vitamin D status was measured as 25OHD concentration in serum
using liquid tandem mass spectrometry by the central laboratory in the
Region Skåne, Sweden. The laboratory is accredited by the Vitamin D
External Quality Assessment Scheme. Details regarding laboratory
analysis and blood sample handling was been described in detail [10].
2.4. Statistical analysis

2. Methods

A cross sectional analysis of the association between 25OHD concentration and random blood glucose at registration in T1 for antenatal
care was performed using linear regression analysis. Two mixed models
analyses were used for investigating the associations between 25OHD
concentration and blood glucose trajectory. Serum 25OHD was included as the independent variable either as 1) categorical 25OHD
concentration at T1 or 2) continuous 25OHD trajectory. The 25OHD
categories were < 30 nmol/L, 30-49.9 nmol/L, 50-74.9 nmol/L and
≥75 nmol/L. For the second model with 25OHD trajectory, 25OHD
measured in T1 and T3a were included, along with the mean of T1 and
T3a as a proxy for T2. T3a was duplicated as T3b to achieve the complete the continuous 25OHD trajectory. Blood glucose trajectory included concentrations at T1, T2, T3a and T3b. Both mixed models
analyses used an autoregressive covariance matrix, as the correlations
decreased with time. Associations between 25OHD concentration and
LGA were assessed using logistic regression analysis. Confounders included in all analyses were maternal age, gestational age at enrolment,
maternal T1 BMI, education, season at sampling and maternal ethnicity.

2.1. Recruitment

3. Results

Women were invited to participate in the GraviD cohort study when
registering for antenatal care in south-west of Sweden (within the regions Södra Bohuslän, Södra Älvsborg and Gothenburg) in autumn
2013 and spring 2014. The only exclusion criterion was pregnancy
exceeding 16 weeks at registration. In the current analysis, 1928
women were included, after additionally exclusion of women with
preexisting diabetes and multifetal pregnancies.

In total, 1928 women were included in this analysis and their
characteristics are described in Table 1. GDM was diagnosed in 11
women, and 40 infants were born LGA. Higher blood glucose in T1 was
associated with significantly increased odds of GDM (OR = 1.949,
p < 0.001), but not with LGA (OR = 0.883, p = 0.383).
Lower vitamin D status in T1 was associated with higher blood
glucose, and those with T1 25OHD concentration ≥30 nmol/L had
0.25-0.35 mmol/L lower blood glucose (depending on 25OHD category) than those with vitamin D deficiency (Table 2). Similarly,
25OHD ≥ 30 nmol/L in T1, was associated with a lower glucose trajectory throughout pregnancy, compared to vitamin D deficient women
(Table 3). Other significant determinants of higher glucose in T1 and
higher glucose trajectory were higher maternal age, BMI and non-North
European origin, while the associations were negative with gestational
age in T1.
The 25OHD trajectory was not associated with glucose trajectory
(Table 4). Significant determinants of higher glucose trajectory were
higher maternal age and higher maternal T1 BMI, lower education and
non-North European origin. Lower glucose trajectory was associated
with higher gestational age at enrolment. 25OHD in T1 was not associated with LGA infant (OR = 1.000, p = 0.991). However, 25OHD in
T3 was significantly associated with higher odds of LGA and the odds
increased by 6% for every 10 nmol/L increase in T3 25OHD (Table 5).

2.2. Sample and data collection
Women were sampled for random (not standardized for fasting and
time during the day) blood glucose according to standard practice of
care by finger prick puncture at four time points; at registration for
antenatal care (T1, gestational weeks 4–16), in the second trimester of
pregnancy (T2, gestational weeks 17–27), in early third trimester (T3a,
gestational weeks 28–35) and late in the third trimester (T3b, gestational weeks 36–42). At T1 and T3a, women were also sampled for
blood collection by venous puncture for analyses of serum 25OHD.
Questionnaires were used in T1 to collect data on ethnicity (country
of birth, divided into North Europe, or non-North Europe), education
level attained (primary, secondary of university level). Season at sampling was coded dichotomously as winter (November-April) or summer
(May-October). Data on maternal body mass index (BMI), maternal age,
gestational age and infant size at birth (as a proxy of fetal growth) were
retrieved from the medical records. Infant birth size, was evaluated for
LGA, defined as weight at birth above 2 standard deviations of the
gender specific population mean, according to standard practice. Data
on blood glucose and diagnosis of GDM were retrieved from the medical
records.

4. Discussion
In this longitudinal population based cohort study, we found that
25OHD concentrations ≥30 nmol/L in early pregnancy was associated
with both lower early pregnancy blood glucose and with lower glucose
trajectory in pregnancy. However, 25OHD trajectory was not associated
with glucose trajectory, and higher vitamin D status in late pregnancy
118
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Table 1
Characteristics of the participating pregnant women.

Maternal age T1 (years)
Maternal BMI T1 (kg/m2)
Gestational week T1
Gestational week T2
Gestational week T3a
Gestational week T3b
Glucose T1 (mmol/L)
Glucose T2 (mmol/L)
Glucose T3a (mmol/L)
Glucose T3b (mmol/L)
25OHD T1 (nmol/L)
25OHD T3a (nmol/L)
Education level
Primary
Secondary
University
Origin
North Europe
America
Continental Europe
Asia
Africa
Season T1
November-April
May-October
Gestational diabetes mellitus
Large for gestational age

N

Mean

Standard deviation

1928
1907
1850
1826
1794
1717
1896
1785
1780
1684
1922
1705
N

31.5
24.4
10.3
25.2
32.4
37.4
5.2
5.3
5.3
5.3
64.5
75.0
%

4.9
4.1
2.2
0.9
1.0
0.8
1.1
1.1
1.1
1.1
24.0
34.0

143
620
1154

7.5
32.3
60.2

1460
35
135
192
106

75.7
1.8
7.0
10.0
5.5

734
1194
11
40

38.1
61.9
0.6
2.2

Table 3
Mixed models analysis of first trimester 25-hydroxyvitamin D and blood glucose
trajectorya during pregnancy.
Estimate

Intercept
25OHD T1
< 30 nmol/L
(ref)
30-49.9 nmol/L
50-74.9 nmol/L
≥75 nmol/L
Gestational week
T1
Maternal age
(years)
Maternal BMI T1
(kg/m2)
Season T1
May-October
(ref)
November-April
Education level
University (ref)
Primary
Secondary
Origin
North European
(ref)
Non-North
European

T, trimester; 25OHD, 25-hydroxyvitamin D; BMI, body mass index.
Table 2
Linear regression analysis of the association between first trimester 25-hydroxyvitamin D and blood glucose.a
Unstandardized Coefficients

25OHD T1
< 30 nmol/L (ref)
30-49.9 nmol/L
50-74.9 nmol/L
≥75 nmol/L
Gestational week T1
Maternal age T1 (years)
Maternal BMI T1 (kg/m2)
Season T1
May-October (ref)
November-April
Origin
North European (ref)
Non-North European
Education level
University (ref)
Primary
Secondary

Standard error

−0.245
−0.273
−0.347
−0.053
0.011
0.013

0.106
0.102
0.106
0.011
0.005
0.006

0.021
0.008
0.001
< 0.001
0.032
0.028

−0.086

0.051

0.089

0.272

0.068

< 0.001

0.229
0.020

0.105
0.056

0.029
0.723

P-value

95% Confidence
Interval
Lower
Bound

Upper
Bound

4.924

0.164

< 0.001

4.603

5.245

−0.129
−0.086
−0.153
−0.036

0.068
0.065
0.067
0.007

0.056
0.183
0.023
< 0.001

−0.262
−0.213
−0.285
−0.050

0.003
0.041
−0.021
−0.022

0.008

0.003

0.020

0.001

0.014

0.021

0.004

< 0.001

0.013

0.028

0.012

0.032

0.694

−0.050

0.075

0.119
−0.010

0.066
0.035

0.070
0.766

−0.010
−0.079

0.248
0.058

0.285

0.042

< 0.001

0.202

0.368

T1, trimester 1; 25OHD, 25-hydroxyvitamin D; BMI, body mass index; ref, reference category.
a
Blood glucose trajectory (mmol/L) as dependent variable, included glucose
concentrations at T1, T2, T3a and T3b.

P-value

B

Standard
error

vitamin D deficient women. Interestingly, the HAPO study showed that
increasing blood glucose levels, less severe than those found in overt
diabetes, are related to clinically important perinatal disorders [3]. An
increase of 0.4 mmol/L in fasting glucose corresponded to significantly
higher odd ratios of serious maternal and neonatal outcomes; e.g.
neonate birthweight > 90th centile, and primary caesarean delivery.
Thus, the effect estimate that we have found where avoidance of vitamin D deficiency was related to lower levels of maternal blood glucose within what is currently considered non-diabetic ranges still may
be of clinical relevance. This indicate the need to study the possible
treatment effects of vitamin D already in early pregnancy on gestational
glucose control in early pregnancy and throughout pregnancy.
Large longitudinal studies addressing the impact of gestation on
vitamin D metabolism are scarce and we are aware of no study that has
examined longitudinal changes in vitamin D metabolism in relation to
gestational blood glucose trajectory. Previous findings from the GraviD
cohort showed a significant increase of approximately 10 nmol/L in
25OHD concentration from early to late gestation [10]. This is consistent with other studies [27,28]. Glucose metabolism in pregnancy
has been found to follow a similar pattern whereby increasing glycaemia is observed from early pregnancy, becoming more apparent in
the second trimester and progressively to term [29]. It is biologically
plausible that changes in vitamin D metabolism may predict changes in
gestational glucose metabolism [11–13], but we did not find that
25OHD trajectory was not associated with glucose trajectory.
It is well-established that mothers with increasing glycaemia are at a
higher risk of giving birth to LGA neonates [3,30]. Previous findings
relating to vitamin D status and infant size at delivery are conflicting
[31,32]. However, given its observed effects on maternal glucose control, one might expect poor vitamin D status to be associated with increased risk of LGA infants. Yet our study found higher rather than

T1, trimester 1; 25OHD, 25-hydroxyvitamin D; BMI, body mass index; ref, reference category.
a
Blood glucose (mmol/L) included as dependent variable.

was associated with higher odds of infant LGA.
Much of previous research on vitamin D and glucose homeostasis in
pregnancy has so far examined the association between maternal vitamin D status and risk of developing GDM [14,15,19–21,25,26].
However, our results suggest that avoiding vitamin D deficiency may
protect from hyperglycaemia, less severe than GDM. Such a relation has
previously been recognised in mid-pregnancy among non-diabetic
pregnant women [14,15], whereas we now show this association in
early pregnancy. For example, women in first trimester with
25OHD ≥ 75 nmol/L had 0.35 mmol/L lower blood glucose than
119
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pregnancy served to explore the temporal relationship between maternal vitamin D deficiency and subsequent blood glucose levels in the
first, second and third trimesters. To the best of the author’s knowledge,
no other studies have prospectively assessed the influence of early vitamin D status on blood glucose trajectory in the pregnant population
or have examined the relation between vitamin D and glucose trajectory in pregnancy, respectively.
It is a limitation that only random blood glucose levels were
available as a surrogate measure of glucose homeostasis in the pregnant
state. Random blood glucose may not perfectly reflect overall glucose
control. Furthermore, it is possible that the observed negative associations between maternal vitamin D status and blood glucose reflect the
impact of co-factors of risk that were not included in this study. The
confounding effects of inflammation, physical activity, visceral adiposity, overall nutritional status and water retention were not included
in the study and thus residual confounding may exist.

Table 4
Mixed models analysis of 25-hydroxyvitamin D trajectoryb and blood glucose
trajectorya during pregnancy.
Estimate

Intercept
25OHD trajectory‡
(nmol/L)
Gestational week
T1
Maternal age T1
(years)
Maternal BMI T1
(kg/m2)
Season T1
May-October
(ref)
November-April
Education
University level
(ref)
Primary level
Secondary level
Origin
North European
(ref)
Non-North
European

Standard
error

P-value

95% Confidence
Interval
Lower
Bound

Upper
Bound

4.907
−0.001

0.162
0.001

< 0.001
0.295

4.589
−0.002

5.225
0.001

−0.041

0.007

< 0.001

−0.056

−0.027

0.008

0.003

0.016

0.001

0.015

0.020

0.004

< 0.001

0.013

0.028

0.019

0.033

0.561

−0.045

0.083

0.145
−0.026

0.066
0.035

0.028
0.472

0.015
−0.095

0.276
0.044

0.306

0.041

< 0.001

0.226

0.386

5. Conclusion
In conclusion, the results from this study indicate that higher maternal vitamin D in early pregnancy associates with lower blood glucose
in early pregnancy and blood glucose trajectory throughout pregnancy.
Higher 25OHD in late pregnancy was associated with higher odds of
LGA at birth. Thus, further well-designed observational and interventional studies are required to determine the explicit effect of vitamin D
on gestational glucose metabolism.
Funding
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Table 5
Logistic regression analysis of 25-hydroxyvitamin D in late pregnancy and the
odds of infant large for gestational age.

25OHD T3 (nmol/L)
Gestational week T1
Maternal age T1 (years)
Maternal BMI T1 (kg/m2)
Education level
University (ref)
Primary
Secondary
Origin
North European (ref)
Non-North European
Season T3
May-October (ref)
November-April

B

Standard error

P-value

Odds ratio

0.006
−0.178
0.055
0.095

0.003
0.040
0.019
0.018

0.032
< 0.001
0.004
< 0.001

1.006
0.837
1.056
1.100

−0.160
−0.162

0.406
0.199

0.701
0.694
0.417

0.852
0.851

−0.275

0.256

0.282

0.759

0.122

0.193

0.529

1.130

Acknowledgements
The authors would like to acknowledge the women participating in
the study, as well as the midwives and nurses whose contributions were
pivotal in the realization of the study.
References
[1] L. Guariguata, U. Linnenkamp, J. Beagley, D.R. Whiting, N.H. Cho, Global estimates
of the prevalence of hyperglycaemia in pregnancy, Diabetes Res. Clin. Pract. 103 (2)
(2014) 176–185.
[2] A. Vambergue, I. Fajardy, Consequences of gestational and pregestational diabetes
on placental function and birth weight, World J. Diabetes 2 (11) (2011) 196–203.
[3] B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, U. Chaovarindr, D.R. Coustan,
et al., Hyperglycemia and adverse pregnancy outcomes, N. Engl. J. Med. 358 (19)
(2008) 1991–2002.
[4] P.S. George, E.R. Pearson, M.D. Witham, Effect of vitamin D supplementation on
glycaemic control and insulin resistance: a systematic review and meta-analysis,
Diabet Med. 29 (8) (2012) e142–50.
[5] H.H. Burris, M.S.L. Rifas-Shiman, K. Kleinman, A.A. Litonjua, S.Y. Huh, J.W. RichEdwards, et al., Vitamin D deficiency in pregnancy and gestational diabetes, Am. J.
Obstet. Gynecol. 207 (3) (2012) 182.e1-.e8.
[6] K.M. Seamans, K.D. Cashman, Existing and potentially novel functional markers of
vitamin D status: a systematic review, Am. J. Clin. Nutr. 89 (6) (2009)
1997s–2008s.
[7] M. Kiely, A. Hemmingway, K.M. O’Callaghan, Vitamin D in pregnancy: current
perspectives and future directions, Ther. Adv. Musculoskelet Dis. 9 (6) (2017)
145–154.
[8] Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D
and Calcium, The national academies collection: reports funded by national institutes of health, in: A.C. Ross, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.),
Dietary Reference Intakes for Calcium and Vitamin D, National Academies Press
(US). National Academy of Sciences, Washington (DC), 2011.
[9] Nordic Council of Ministers, Nordic Nutrition Recommendations, 5th edition,
(2012), p. 2014.
[10] L. Barebring, I. Schoenmakers, A. Glantz, L. Hulthen, A. Jagner, J. Ellis, et al.,

T1, trimester 1; T3, trimester 3; 25OHD, 25-hydroxyvitamin D; BMI, body mass
index; ref, reference category.

lower vitamin D status was associated with higher odds of LGA infants.
The exact effects of vitamin D deficiency coupled with increasing maternal glucose on foetal growth remains a largely unknown mechanism
that requires further exploration.
One strength is that this study include the large prospective cohort
with participants from multiple ethnic groups and a comparable study
sample to the general Swedish population in terms of BMI, ethnicity
and parity [33]. Another strength is the use of the liquid chromatography-mass spectrometry method used to assess 25OHD concentration, since it is considered the gold standard for valid estimation of
vitamin D status. The determination of 25OHD concentrations in early
120

Journal of Steroid Biochemistry and Molecular Biology 186 (2019) 117–121

M. Walsh et al.

[11]
[12]
[13]

[14]
[15]
[16]

[17]
[18]
[19]
[20]
[21]

[22]

Vitamin D Status during pregnancy in a multi-ethnic population-representative
Swedish cohort, Nutrients 8 (10) (2016).
S.A. Clark, W.E. Stumpf, M. Sar, Effect of 1,25 dihydroxyvitamin D3 on insulin
secretion, Diabetes 30 (5) (1981) 382.
J.A. Alvarez, A. Ashraf, Role of vitamin D in insulin secretion and insulin sensitivity
for glucose homeostasis, Int. J. Endocrinol. (2010) (2010) 351385.
F. Haidari, M.-T. Jalali, N. Shahbazian, M.-H. Haghighizadeh, E. Azadegan,
Comparison of serum levels of vitamin D and inflammatory markers between
women with gestational diabetes mellitus and healthy pregnant control, J. Fam.
Reprod. Health. 10 (1) (2016) 1–8.
Z. Maghbooli, A. Hossein‐nezhad, F. Karimi, A.R. Shafaei, B. Larijani, Correlation
between vitamin D3 deficiency and insulin resistance in pregnancy, Diabetes
Metab. Res. Rev. 24 (1) (2007) 27–32.
R.J. Clifton‐Bligh, P. McElduff, A. McElduff, Maternal vitamin D deficiency, ethnicity and gestational diabetes, Diabet Med. 25 (6) (2008) 678–684.
F. Aghajafari, T. Nagulesapillai, P.E. Ronksley, S.C. Tough, M. O’Beirne, D.M. Rabi,
Association between maternal serum 25-hydroxyvitamin D level and pregnancy and
neonatal outcomes: systematic review and meta-analysis of observational studies,
BMJ 346 (2013) f1169.
S.Q. Wei, H.P. Qi, Z.C. Luo, W.D. Fraser, Maternal vitamin D status and adverse
pregnancy outcomes: a systematic review and meta-analysis, J. Matern. Fetal.
Neonatal. Med. 26 (9) (2013) 889–899.
M.X. Zhang, G.T. Pan, J.F. Guo, B.Y. Li, L.Q. Qin, Z.L. Zhang, Vitamin D deficiency
increases the risk of gestational diabetes mellitus: a meta-analysis of observational
studies, Nutrients. 7 (10) (2015) 8366–8375.
M. Lu, Y. Xu, L. Lv, M. Zhang, Association between vitamin D status and the risk of
gestational diabetes mellitus: a meta-analysis, Arch. Gynecol. Obstet. 293 (5)
(2016) 959–966.
M. Lacroix, M.C. Battista, M. Doyon, G. Houde, J. Menard, J.L. Ardilouze, et al.,
Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus, Acta Diabetol. 51 (4) (2014) 609–616.
S. Park, H.-K. Yoon, H.-M. Ryu, Y.J. Han, S.W. Lee, B.K. Park, et al., Maternal vitamin D deficiency in early pregnancy Is not associated with gestational diabetes
mellitus development or pregnancy outcomes in Korean pregnant women in a
prospective study, J. Nutr. Sci. Vitaminol. (Tokyo) 60 (4) (2014) 269–275.
F.J. Schneuer, C.L. Roberts, C. Guilbert, J.M. Simpson, C.S. Algert, A.Z. Khambalia,
et al., Effects of maternal serum 25-hydroxyvitamin D concentrations in the first

[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]

[32]
[33]

121

trimester on subsequent pregnancy outcomes in an Australian population, Am. J.
Clin. Nutr. 99 (2) (2014) 287–295.
L. Parlea, I.L. Bromberg, D.S. Feig, R. Vieth, E. Merman, L.L. Lipscombe, Association
between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational
diabetes mellitus, Diabet. Med. 29 (7) (2012) e25–32.
D.L. Arnold, D.A. Enquobahrie, C. Qiu, J. Huang, N. Grote, A. VanderStoep, et al.,
Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes
mellitus, Paediatr. Perinat. Epidemiol. 29 (3) (2015) 200–210.
A.M. Baker, S. Haeri, C.A. Camargo Jr., A.M. Stuebe, K.A. Boggess, First-trimester
maternal vitamin D status and risk for gestational diabetes (GDM) a nested casecontrol study, Diabetes Metab. Res. Rev. 28 (2) (2012) 164–168.
L.M. De-Regil, C. Palacios, L.K. Lombardo, J.P. Pena-Rosas, Vitamin D supplementation for women during pregnancy, Cochrane Database Syst. Rev. (1) (2016)
Cd008873.
J.Y. Zhang, A.J. Lucey, R. Horgan, L.C. Kenny, M. Kiely, Impact of pregnancy on
vitamin D status: a longitudinal study, Br. J. Nutr. 112 (7) (2014) 1081–1087.
A. Lundqvist, H. Sandstrom, H. Stenlund, I. Johansson, J. Hultdin, Vitamin D status
during pregnancy: a longitudinal study in Swedish women from early pregnancy to
seven months postpartum, PLoS One. 11 (3) (2016) e0150385.
A.R. Angueira, A.E. Ludvik, T.E. Reddy, B. Wicksteed, W.L. Lowe, B.T. Layden, New
insights into gestational glucose metabolism: lessons learned from 21st century
approaches, Diabetes 64 (2) (2015) 327–334.
O. Langer, R. Mazze, The relationship between large-for-gestational-age infants and
glycemic control in women with gestational diabetes, Am. J. Obstet. Gynecol. 159
(6) (1988) 1478–1483.
A. Rodriguez, R. Garcia-Esteban, M. Basterretxea, A. Lertxundi, C. RodriguezBernal, C. Iniguez, et al., Associations of maternal circulating 25-hydroxyvitamin
D3 concentration with pregnancy and birth outcomes, BJOG 122 (12) (2015)
1695–1704.
A.D. Gernand, H.N. Simhan, S. Caritis, L.M. Bodnar, Maternal vitamin D Status and
small-for-gestational-age offspring in women at High risk for preeclampsia,
Obstetrics Gynecol. 123 (1) (2014) 40–48.
Swedish National Board of Health and Welfare. Sweden Pregnancies, Deliveries,
and Newborn Infants 2015: National Board of Health and Welfare (Sweden); 2018
[Available from: http://ghdx.healthdata.org/record/sweden-pregnanciesdeliveries-and-newborn-infants-2015.

